Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,385 | 181,101 | 64,524 | 83,958 | 44,679 |
| Marketable Securities | 155,947 | 136,015 | 15,848 | 19,970 | 38,594 |
| Other current assets | 3,893 | 1,333 | 1,304 | 2,047 | 2,057 |
| TOTAL | $212,341 | $334,347 | $94,452 | $113,731 | $99,572 |
| Non-Current Assets | |||||
| PPE Net | 105,217 | 82,863 | 69,878 | 89,023 | 80,875 |
| Investments And Advances | 865 | 7,597 | 802 | 822 | 1,000 |
| Intangibles | 22,349 | 1,420 | 1,432 | 1,445 | 1,438 |
| Other Non-Current Assets | 48,815 | 42,683 | 47,857 | 41,280 | 26,543 |
| TOTAL | $177,246 | $134,563 | $119,969 | $132,570 | $109,856 |
| Total Assets | $389,587 | $468,910 | $214,421 | $246,301 | $209,428 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,427 | 15,361 | 23,817 | 35,864 | 37,914 |
| Accrued Expenses | 62,468 | 51,387 | 38,519 | 36,134 | 36,793 |
| TOTAL | $381,014 | $368,995 | $65,408 | $74,428 | $79,863 |
| Non-Current Liabilities | |||||
| Long Term Debt | 309,428 | 306,349 | 303,240 | 300,252 | 297,286 |
| Other Non-Current Liabilities | 36,711 | 37,773 | 36,347 | 31,133 | 18,312 |
| TOTAL | $346,129 | $343,828 | $338,957 | $330,458 | $314,901 |
| Total Liabilities | $727,143 | $712,823 | $404,365 | $404,886 | $394,764 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 397,957 | 397,911 | 397,595 | 391,157 | 383,906 |
| Common Shares | 40 | 40 | 39 | 39 | 38 |
| Retained earnings | -2,064,747 | -1,961,921 | -1,870,662 | -1,783,033 | -1,694,745 |
| Other shareholders' equity | -2,279 | -1,736 | -1,393 | -609 | 413 |
| TOTAL | $-337,556 | $-243,913 | $-189,944 | $-158,585 | $-185,336 |
| Total Liabilities And Equity | $389,587 | $468,910 | $214,421 | $246,301 | $209,428 |